Two experimental protocols will be employed to examine the role of gene enhancer signals in regulating gene expression of viruses in a tissue restricted fashion. 1. Transgenic mice with SV40 DNA in all cells and the germ line have been obtained. With several independently derived mice of this type there is a tissue restricted or preferred gene expression of SV40 mRNA and tumor antigen (brain, thymus, kidney). Similarly there is a tissue limited or preferred SV40 induced tumorigenesis in these transgenic mice. Experiments have been designed to determine which genetic elements of SV40 DNA (gene enhancer, T-antigen, t-antigen) are responsible for tissue limited gene expression and/or tumorigenesis in these transgenic mice. Transgenic mice containing viral """"""""immortality"""""""" gene functions of polyoma, adenovirus and SV40 will be obtained and the role of these gene products in tumorigenesis will be studied. Permanent cell lines derived from a variety of tissues of these transgenic mice can be useful to study developmental questions or detect possible oncogenes. 2. The role of the polyoma gene enhancer sequences in regulating gene expression in embryonal carcinoma cells and a variety of differentiated cell types will be studied. Several methods for obtaining gene enhancer mutants with a cell or tissue preference are described. Such gene enhancer mutants should be useful in experiments with transgenic mice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA038757-01
Application #
3177006
Study Section
Virology Study Section (VR)
Project Start
1984-12-01
Project End
1989-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Princeton University
Department
Type
Schools of Arts and Sciences
DUNS #
002484665
City
Princeton
State
NJ
Country
United States
Zip Code
Wilson, J B; Ferguson, M W; Jenkins, N A et al. (1993) Transgenic mouse model of X-linked cleft palate. Cell Growth Differ 4:67-76
Tevethia, S S; Epler, M; Georgoff, I et al. (1992) Antibody response to human papovavirus JC (JCV) and simian virus 40 (SV40) T antigens in SV40 T antigen-transgenic mice. Virology 190:459-64
Zambetti, G P; Quartin, R S; Martinez, J et al. (1991) Regulation of transformation and the cell cycle by p53. Cold Spring Harb Symp Quant Biol 56:219-25
Martinez, J; Georgoff, I; Martinez, J et al. (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5:151-9
Levine, A J; Momand, J (1990) Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products. Biochim Biophys Acta 1032:119-36
Wilson, J B; Weinberg, W; Johnson, R et al. (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315-27
Cho, H J; Seiberg, M; Georgoff, I et al. (1989) Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas. J Neurosci Res 24:115-22
Marks, J R; Lin, J; Hinds, P et al. (1989) Cellular gene expression in papillomas of the choroid plexus from transgenic mice that express the simian virus 40 large T antigen. J Virol 63:790-7
Levine, A J (1988) Oncogenes of DNA tumor viruses. Cancer Res 48:493-6
Yagaloff, K A; Lozano, G; van Dyke, T et al. (1986) Serotonin 5-HT1C receptors are expressed at high density on choroid plexus tumors from transgenic mice. Brain Res 385:389-94

Showing the most recent 10 out of 11 publications